ARCHIVES

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

This article is from The Cancer Letter archive.

Vol. 12 No. 35 | September 12, 1986

Download PDF Visit The Full Archive

Related Articles

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

AACR Receives Record Number of Abstracts

January 27, 1989

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997